Nuclear Structure-Function Defects in the Pathogenesis of Muscular Dystrophy (R21)

The summary for the Nuclear Structure-Function Defects in the Pathogenesis of Muscular Dystrophy (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Nuclear Structure-Function Defects in the Pathogenesis of Muscular Dystrophy (R21): This funding announcement (FOA) solicits Exploratory/Developmental (R21) grant applications from applicant organizations that propose to identify the mechanisms of a subset of muscular dystrophies that may have their basis in nucleus structure-function defects. Applications are specifically solicited for studies of Emery-Dreifuss, facioscapulohumeral, limb girdle muscular dystrophy 1B, and oculopharyngeal muscular dystrophies. Applications for studies of other muscular dystrophies are not responsive to this RFA. The expected outcomes are improvements in understanding of the genetic, cell, and molecular mechanisms of these muscular dystrophies. Applicants who can bring knowledge and expertise in the biology of the nucleus to studies of disease mechanisms are particularly encouraged. -The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to commit approximately $2 million in total costs in FY 2007 for this announcement and its companion RFA (RFA-NS-07-001) to support a combined total of 4-7 meritorious applications. The MDA will support additional meritorious applications received and reviewed under this RFA, to the extent that funds are available within its current research budget. -This funding opportunity will use the NIH research grant (R21) award mechanism. -The R21 is not renewable. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. -Eligible organizations: For profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals and laboratories; Units of State government; Units of local government; Eligible institutions of the Federal government; Domestic institutions; Foreign institutions; Faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization. -Eligible Project Directors/Principal Investigators (PD/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct. -All investigator-initiated exploratory/developmental grant applications described in this announcement will be assigned to Institutes and Centers (ICs) according to standard Public Health Service (PHS) referral guidelines and specific program interests.